What brokerages make of Dr Lal PathLabs, Amber Enterprises, Cement stocks today?

Here's what UBS, CLSA and HSBC make of stocks including Dr Lal PathLabs, Shree Cement, Dalmia Bharat and Amber Enterprises:

ZeeBiz WebTeam | Mar 22, 2024, 08:47 AM IST

As Dalal Street enters the March 22 session, brokerages have few stocks on their radar. Here's what UBS, CLSA and HSBC make of stocks including Dr Lal PathLabs, Shree Cement, Dalmia Bharat and Amber Enterprises:

1/5

Dr Lal PathLabs share price target

Dr Lal PathLabs share price target

Dr Lal PathLabs share price target: UBS has maintained a 'buy' call on the Dr Lal PathLabs stock with a target of Rs 2,900.

2/5

Brokerage on Cement: Shree Cement, Dalmia Bharat

Brokerage on Cement: Shree Cement, Dalmia Bharat

HSBC has maintained its ratings on Cement stocks including Shree Cement and Dalmia Bharat.

3/5

Shree Cement share price target

Shree Cement share price target

Shree Cement share price target: HSBC has maintained a 'hold' call on the Shree Cement stock with a target of Rs 25,000.

4/5

Dalmia Bharat share price target

Dalmia Bharat share price target

Dalmia Bharat share price target: HSBC has maintained a 'buy' call on the Dalmia Bharat stock with a target of Rs 2,500.

5/5

Amber Enterprises share price target

Amber Enterprises share price target

Amber Enterprises share price target: CLSA has maintained a 'buy' call on the Amber Enterprises stock with a target of Rs 4,300.

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x